Axitinib
targeted anticancer therapy · kinase inhibitor
Nothing to addBy the Layer Nutrition editorial team · How the atlas classifies the 664 molecules
What this medicine is for
Pharmacologically, Axitinib relates to the category “targeted anticancer therapy (kinase inhibitor)”. This targeted therapy attacks a specific mechanism of tumor cells; it falls under a specialized hospital prescription.
Specifically, for Axitinib: Treats a cancer by targeting tumor cells. It is part of specialized, closely monitored care.
Under which brands it is found
In France, about 5 reimbursable presentations containing Axitinib are recorded. It comes under various trade names and in generic form.
- Axitinib Biogaran
- Axitinib Eg
- Axitinib Sandoz
- Axitinib Teva
- Inlyta
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
Nous n'avançons aucun complément pour Axitinib : ce serait forcer un besoin qui n'existe pas. La grande majorité des médicaments n'appellent aucune supplémentation particulière, et le reconnaître fait partie de notre manière de travailler. Nous ne concevons un complément que là où les données le soutiennent.
Related molecules
To explore in the « Other areas » family and its neighbours.